by Extreme-level Multiplexing in Digital PCR With Intercalating Dyes by Coupling Precise-Time Kinetics and Melting Curve Analysis
Digital polymerase chain response (dPCR) is a mature strategy that has enabled scientific breakthroughs in a lot of fields. Nonetheless, this know-how is primarily utilized in evaluation environments with high-level multiplexing representing a major problem. Proper right here, we propose a novel approach for multiplexing, often known as amplification and melting curve analysis (AMCA), which leverages the kinetic information in real-time amplification info and the thermodynamic melting profile using a reasonable intercalating dye (EvaGreen).
The technique trains a system comprised of supervised machine learning fashions for proper classification, by benefit of the huge amount of knowledge from dPCR platforms. As a case analysis, we develop a model new 9-plex assay to detect mobilised colistin resistant (mcr) genes as clinically associated targets for antimicrobial resistance. Over 100,000 amplification events have been analysed, and for the optimistic reactions, the AMCA methodology experiences a classification accuracy of 99.33 ± 0.13%, an increase of 10.0% over using melting curve analysis. This work provides an cheap strategy of high-level multiplexing with out fluorescent probes, extending some great benefits of dPCR in evaluation and scientific settings.
anti-GPCR GPR110 |
|||
| YF-PA22867 | Abfrontier | 50 ul | 435.6 EUR |
|
Description: Mouse polyclonal to GPCR GPR110 |
|||
anti-GPCR GPR110 |
|||
| YF-PA22868 | Abfrontier | 50 ug | 435.6 EUR |
|
Description: Mouse polyclonal to GPCR GPR110 |
|||
GPR110 Antibody |
|||
| 1-CSB-PA002753 | Cusabio |
|
|
|
Description: A polyclonal antibody against GPR110. Recognizes GPR110 from Human. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/40000 |
|||
GPR110 Antibody |
|||
| DF2796 | Affbiotech | 200ul | 420 EUR |
GPR110 Antibody |
|||
| DF4891 | Affbiotech | 200ul | 420 EUR |
GPR110 antibody |
|||
| 70R-51217 | Fitzgerald | 100 ul | 292.8 EUR |
|
Description: Purified Polyclonal GPR110 antibody |
|||
GPR110 antibody |
|||
| 70R-31396 | Fitzgerald | 100 ug | 392.4 EUR |
|
Description: Rabbit polyclonal GPR110 antibody |
|||
GPR110 Antibody |
|||
| 44961-100ul | SAB | 100ul | 302.4 EUR |
GPR110 Antibody |
|||
| 44961-50ul | SAB | 50ul | 224.4 EUR |
GPR110 Antibody |
|||
| ABD2796 | Lifescience Market | 100 ug | 525.6 EUR |
GPR110 Antibody |
|||
| ABD4891 | Lifescience Market | 100 ug | 525.6 EUR |
Rabbit Polyclonal antibody Anti-CRBN |
|||
| Anti-CRBN | ImmunoStep | 50 µg | 418.8 EUR |
GPR110 Conjugated Antibody |
|||
| C44961 | SAB | 100ul | 476.4 EUR |
GPR110 Polyclonal Antibody |
|||
| ES2448-100ul | ELK Biotech | 100ul | 334.8 EUR |
|
Description: A Rabbit Polyclonal antibody against GPR110 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
GPR110 Polyclonal Antibody |
|||
| ES2448-50ul | ELK Biotech | 50ul | 248.4 EUR |
|
Description: A Rabbit Polyclonal antibody against GPR110 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
GPR110 Polyclonal Antibody |
|||
| ABP51449-003ml | Abbkine | 0.03ml | 189.6 EUR |
|
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
|||
GPR110 Polyclonal Antibody |
|||
| ABP51449-01ml | Abbkine | 0.1ml | 346.8 EUR |
|
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
|||
GPR110 Polyclonal Antibody |
|||
| ABP51449-02ml | Abbkine | 0.2ml | 496.8 EUR |
|
Description: A polyclonal antibody for detection of GPR110 from Human. This GPR110 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the C-terminal region of human GPR110 at AA range: 810-890 |
|||
Polyclonal GPR110 Antibody |
|||
| APR12205G | Leading Biology | 0.1ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR110 . This antibody is tested and proven to work in the following applications: |
|||
GPR110 siRNA |
|||
| 20-abx918404 | Abbexa |
|
|
GPR110 siRNA |
|||
| 20-abx918405 | Abbexa |
|
|
GPR110 Blocking Peptide |
|||
| DF2796-BP | Affbiotech | 1mg | 234 EUR |
GPR110 Blocking Peptide |
|||
| DF4891-BP | Affbiotech | 1mg | 234 EUR |
GPR110 Blocking Peptide |
|||
| 20-abx064092 | Abbexa |
|
|
Mouse GPR110 shRNA Plasmid |
|||
| 20-abx978802 | Abbexa |
|
|
Human GPR110 shRNA Plasmid |
|||
| 20-abx966836 | Abbexa |
|
|
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | 336 EUR |
Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | 336 EUR |
Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | 336 EUR |
GPR110 ORF Vector (Human) (pORF) |
|||
| ORF020338 | ABM | 1.0 ug DNA | 486 EUR |
Gpr110 ORF Vector (Mouse) (pORF) |
|||
| ORF046467 | ABM | 1.0 ug DNA | 607.2 EUR |
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| 20-abx147426 | Abbexa |
|
|
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| 20-abx015251 | Abbexa |
|
|
G Protein-Coupled Receptor 110 (GPR110) Antibody |
|||
| 20-abx007923 | Abbexa |
|
|
GPR110 sgRNA CRISPR Lentivector set (Human) |
|||
| K0894901 | ABM | 3 x 1.0 ug | 406.8 EUR |
Gpr110 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3842201 | ABM | 3 x 1.0 ug | 406.8 EUR |
GPR110 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0894902 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR110 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0894903 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR110 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0894904 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr110 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3842202 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr110 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3842203 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr110 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3842204 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR110 Protein Vector (Human) (pPB-C-His) |
|||
| PV081349 | ABM | 500 ng | 662.4 EUR |
GPR110 Protein Vector (Human) (pPB-N-His) |
|||
| PV081350 | ABM | 500 ng | 662.4 EUR |
GPR110 Protein Vector (Human) (pPM-C-HA) |
|||
| PV081351 | ABM | 500 ng | 662.4 EUR |
GPR110 Protein Vector (Human) (pPM-C-His) |
|||
| PV081352 | ABM | 500 ng | 662.4 EUR |
GPR110 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV185866 | ABM | 500 ng | 1278 EUR |
GPR110 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV185867 | ABM | 500 ng | 1278 EUR |
GPR110 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV185868 | ABM | 500 ng | 1278 EUR |
GPR110 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV185869 | ABM | 500 ng | 1278 EUR |
Gpr110 3'UTR Luciferase Stable Cell Line |
|||
| TU108961 | ABM | 1.0 ml | Ask for price |
Gpr110 3'UTR GFP Stable Cell Line |
|||
| TU158961 | ABM | 1.0 ml | Ask for price |
GPR110 3'UTR GFP Stable Cell Line |
|||
| TU059201 | ABM | 1.0 ml | 1825.2 EUR |
GPR110 3'UTR Luciferase Stable Cell Line |
|||
| TU009201 | ABM | 1.0 ml | 1825.2 EUR |
Mouse G- protein coupled receptor 110, Gpr110 ELISA KIT |
|||
| ELI-09748m | Lifescience Market | 96 Tests | 1038 EUR |
GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0894905 | ABM | 3 x 1.0 ug | 451.2 EUR |
Human Probable G- protein coupled receptor 110, GPR110 ELISA KIT |
|||
| ELI-08749h | Lifescience Market | 96 Tests | 988.8 EUR |
Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3842205 | ABM | 3 x 1.0 ug | 451.2 EUR |
GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0894906 | ABM | 1.0 ug DNA | 200.4 EUR |
GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0894907 | ABM | 1.0 ug DNA | 200.4 EUR |
GPR110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0894908 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3842206 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3842207 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr110 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3842208 | ABM | 1.0 ug DNA | 200.4 EUR |
Anti-Anti-SEPT6 antibody antibody |
|||
| STJ11100949 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT9 Antibody antibody |
|||
| STJ111369 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ111530 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT4 Antibody antibody |
|||
| STJ112276 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
Anti-Anti-MARCH9 Antibody antibody |
|||
| STJ112609 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ25475 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ25477 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ25479 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ28365 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ28963 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT1 antibody antibody |
|||
| STJ119580 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
|||
Anti-Anti-SEPT12 Antibody antibody |
|||
| STJ117759 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118549 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118550 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH7 Antibody antibody |
|||
| STJ118752 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT3 Antibody antibody |
|||
| STJ118990 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ113941 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ114081 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ114819 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-MARCH8 Antibody antibody |
|||
| STJ114828 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ116214 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ117206 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-DDB1 Antibody |
|||
| A00333 | BosterBio | 100uL | 546 EUR |
|
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 6777.36 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 663.31 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 896.16 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3672.72 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| 4-AEA465Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody) |
|||
| ELK8071 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
|
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Anti-H4K20me1 Antibody |
|||
| CI1005 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me1 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-H4K20me3 Antibody |
|||
| CI1011 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me3 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-TIP5 Antibody |
|||
| CI1016 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal TIP5 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human, Mouse. |
|||
Anti-H4K8ac Antibody |
|||
| CI1021 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K8ac Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-MYH11 Antibody |
|||
| CI1028 | BosterBio | 100ul | 589.2 EUR |
|
Description: Rabbit Polyclonal MYH11 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IHC, WB and tested in Human. |
|||
Anti-Ski3 Antibody |
|||
| CI1031 | BosterBio | 150ug/50ul | 589.2 EUR |
|
Description: Rabbit Polyclonal Ski3 Antibody. Validated in ChIP, ChIP-qPCR, IF, IHC, WB and tested in Human. |
|||
Anti-Ski8 Antibody |
|||
| CI1032 | BosterBio | 150ug/60ul | 589.2 EUR |
|
Description: Rabbit Polyclonal Ski8 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Drosophila, Human. |
|||
Anti-H4K5,8,12ac Antibody |
|||
| CI1033 | BosterBio | 50ug/66ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K5,8,12ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4K5,8,12,16ac Antibody |
|||
| CI1035 | BosterBio | 50ug/66ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K5,8,12,16ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4K5ac Antibody |
|||
| CI1036 | BosterBio | 50ug/28ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K5ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4K20me1 Antibody |
|||
| CI1039 | BosterBio | 50ug/25ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me1 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-MeCP2 Antibody |
|||
| CI1047 | BosterBio | 50ug/42ul | 589.2 EUR |
|
Description: Rabbit Polyclonal MeCP2 Antibody. Validated in ChIP, ChIP-qPCR, WB and tested in Human. |
|||
Anti-H4K20me3 Antibody |
|||
| CI1050 | BosterBio | 50ug/47ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K20me3 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, Flow Cytometry, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H3K27me3 Antibody |
|||
| CI1056 | BosterBio | 50ug/34ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H3K27me3 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IF, IHC, WB and tested in Arabidopsis, Drosophila, Human, Mouse, Rat, Schistosoma, Zebrafish. |
|||
Anti-MBD1 Antibody |
|||
| CI1058 | BosterBio | 50ug/72ul | 589.2 EUR |
|
Description: Rabbit Polyclonal MBD1 Antibody. Validated in ChIP, ChIP-qPCR, Flow Cytometry, WB and tested in Human, Mouse. |
|||
Anti-p53 Antibody |
|||
| CI1060 | BosterBio | 50ug/50ul | 589.2 EUR |
|
Description: Rabbit Polyclonal p53 Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, Flow Cytometry, IHC, WB and tested in Human. |
|||
Anti-H4K8ac Antibody |
|||
| CI1066 | BosterBio | 50ug/41ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4K8ac Antibody. Validated in ChIP, ChIP-qPCR, Flow Cytometry, IF, IHC, WB and tested in Human, Mouse. |
|||
Anti-H4pan Antibody |
|||
| CI1069 | BosterBio | 50ug/44ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H4pan Antibody. Validated in ChIP, ChIP-qPCR, Flow Cytometry, WB and tested in Human. |
|||
Anti-H2AK5ac Antibody |
|||
| CI1078 | BosterBio | 50ug/ 54ul | 589.2 EUR |
|
Description: Rabbit Polyclonal H2AK5ac Antibody. Validated in ChIP, ChIP-qPCR, ChIP-seq, IHC, WB and tested in Human. |
|||
Antibody Anti-cKit |
|||
| CKITACPO | ImmunoStep | 0,1 mg | 379.8 EUR |
anti- LIN28B antibody |
|||
| FNab04785 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN28B |
|||
anti- LIN41 antibody |
|||
| FNab04787 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN41 |
|||
anti- LIN7A antibody |
|||
| FNab04788 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LIN7A |
|||
anti- LIN7B antibody |
|||
| FNab04789 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN7B |
|||
anti- LIN7C antibody |
|||
| FNab04790 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LIN7C |
|||
anti- LIN9 antibody |
|||
| FNab04791 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIN9 |
|||
anti- LINGO1 antibody |
|||
| FNab04792 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LINGO1 |
|||
anti- LIPA antibody |
|||
| FNab04793 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIPA |
|||
anti- LIPC antibody |
|||
| FNab04794 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIPC |
|||
anti- LIPH antibody |
|||
| FNab04795 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LIPH |
|||
anti- LIPI antibody |
|||
| FNab04796 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LIPI |
|||
anti- LITAF antibody |
|||
| FNab04798 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LITAF |
|||
anti- LKB1 antibody |
|||
| FNab04802 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LKB1 |
|||
anti- LMAN1 antibody |
|||
| FNab04803 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMAN1 |
|||
anti- LMBR1L antibody |
|||
| FNab04804 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMBR1L |
|||
anti- LMF1 antibody |
|||
| FNab04805 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMF1 |
|||
anti- LMF2 antibody |
|||
| FNab04806 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMF2 |
|||
anti- LMNB2 antibody |
|||
| FNab04807 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMNB2 |
|||
anti- LMOD1 antibody |
|||
| FNab04808 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMOD1 |
|||
anti- LMOD3 antibody |
|||
| FNab04809 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMOD3 |
|||
anti- LMP2 antibody |
|||
| FNab04810 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMP2 |
|||
anti- LMP7 antibody |
|||
| FNab04811 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LMP7 |
|||
anti- LMX1B antibody |
|||
| FNab04812 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LMX1B |
|||
anti- LNPEP antibody |
|||
| FNab04813 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LNPEP |
|||
anti- LNX1 antibody |
|||
| FNab04814 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LNX1 |
|||
anti- LOC123688 antibody |
|||
| FNab04815 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LOC123688 |
|||
anti- LOC286135 antibody |
|||
| FNab04816 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LOC286135 |
|||
anti- LOC55908 antibody |
|||
| FNab04817 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LOC55908 |
|||
anti- LOC84740 antibody |
|||
| FNab04818 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LOC84740 |
|||
anti- LOH12CR1 antibody |
|||
| FNab04819 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LOH12CR1 |
|||
anti- LONP1 antibody |
|||
| FNab04820 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LONP1 |
|||
anti- LONP1 antibody |
|||
| FNab04821 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LONP1 |
|||
anti- Loricrin antibody |
|||
| FNab04822 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against Loricrin |
|||
anti- LOX antibody |
|||
| FNab04823 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LOX |
|||
anti- LPAR4 antibody |
|||
| FNab04824 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPAR4 |
|||
anti- LPCAT1 antibody |
|||
| FNab04825 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LPCAT1 |
|||
anti- LPCAT1 antibody |
|||
| FNab04826 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPCAT1 |
|||
anti- LPCAT2 antibody |
|||
| FNab04827 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LPCAT2 |
|||
anti- LPCAT4 antibody |
|||
| FNab04828 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPCAT4 |
|||
anti- LPHN3 antibody |
|||
| FNab04829 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPHN3 |
|||
anti- LPIN2 antibody |
|||
| FNab04830 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPIN2 |
|||
anti- LPL antibody |
|||
| FNab04831 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPL |
|||
anti- LPO antibody |
|||
| FNab04834 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LPO |
|||
anti- LPP antibody |
|||
| FNab04835 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPP |
|||
anti- LPPR2 antibody |
|||
| FNab04836 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LPPR2 |
|||
anti- LPXN antibody |
|||
| FNab04837 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LPXN |
|||
anti- LRAT antibody |
|||
| FNab04838 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRAT |
|||
anti- LRCH1 antibody |
|||
| FNab04839 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRCH1 |
|||
anti- LRCH2 antibody |
|||
| FNab04840 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRCH2 |
|||
anti- LRCH3 antibody |
|||
| FNab04841 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRCH3 |
|||
anti- LRDD antibody |
|||
| FNab04842 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRDD |
|||
anti- LRG1 antibody |
|||
| FNab04843 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRG1 |
|||
anti- LRMP antibody |
|||
| FNab04844 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRMP |
|||
anti- LRMP antibody |
|||
| FNab04845 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRMP |
|||
anti- LRP2BP antibody |
|||
| FNab04846 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRP2BP |
|||
anti- LRP5 antibody |
|||
| FNab04848 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRP5 |
|||
anti- LRPAP1 antibody |
|||
| FNab04849 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRPAP1 |
|||
anti- LRPPRC antibody |
|||
| FNab04850 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRPPRC |
|||
anti- LRRC1 antibody |
|||
| FNab04852 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC1 |
|||
anti- LRRC10 antibody |
|||
| FNab04853 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC10 |
|||
anti- LRRC18 antibody |
|||
| FNab04854 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC18 |
|||
anti- LRRC20 antibody |
|||
| FNab04855 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC20 |
|||
anti- LRRC29 antibody |
|||
| FNab04856 | FN Test | 100µg | 702 EUR |
|
Description: Antibody raised against LRRC29 |
|||
anti- LRRC41 antibody |
|||
| FNab04857 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRC41 |
|||
anti- LRRC47 antibody |
|||
| FNab04858 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC47 |
|||
anti- LRRC4C antibody |
|||
| FNab04859 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC4C |
|||
anti- LRRC52 antibody |
|||
| FNab04860 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRC52 |
|||
anti- LRRC8C antibody |
|||
| FNab04861 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRC8C |
|||
anti- LRRC8D antibody |
|||
| FNab04862 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRC8D |
|||
anti- LRRTM1 antibody |
|||
| FNab04863 | FN Test | 100µg | 606.3 EUR |
|
Description: Antibody raised against LRRTM1 |
|||
anti- LRRTM2 antibody |
|||
| FNab04864 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRTM2 |
|||
anti- LRRTM4 antibody |
|||
| FNab04865 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRRTM4 |
|||
anti- LRSAM1 antibody |
|||
| FNab04866 | FN Test | 100µg | 658.5 EUR |
|
Description: Antibody raised against LRSAM1 |
|||
Detection of Helicobacter pylori in gastric most cancers tissue through histopathology, immunohistochemistry and real-time reverse transcription-PCR
Intention:Helicobacter pylori is commonly detected based on hematoxylin-eosin (H-E) choices, nonetheless, immunohistochemistry (IHC) and real-time PCR (RT-PCR) are further actual in chronic-gastritis. We evaluated the relevance of these checks in Peruvian gastric most cancers samples.
Provides & methods: We carried out and evaluated H-E, IHC staining and RT-PCR in 288 gastric tumors. Slides have been independently evaluated by three pathologists.
Outcomes:H. pylori was detected in 167/287 through H-E, 140/288 through IHC and 175/288 through RT-PCR, and positive-status have been associated (p < 0.001). H. pylori detection by H-E had a superb concordance with IHC (kappa index = 0.632) nonetheless poor with RT-PCR (kappa index = 0.317). Larger median gene-copies have been current in extreme H. pylori density through H-E or IHC (p < 0.001).
Conclusion: H-E evaluation is appropriate in gastric most cancers, and IHC and RT-PCR can complement its outcomes.
Analytical validation of the droplet digital PCR assay for prognosis of spinal muscular atrophy
Background: Spinal muscular atrophy (SMA) is a progressive motor neuron sickness attributable to homozygote lack of exon 7 on the survival motor neuron 1 (SMN1) gene. The severity of the SMA phenotype is influenced by copies of SMN2, a gene that is extraordinarily homologous with SMN1.
Methods: We validated analytical effectivity of droplet digital polymerase chain response (ddPCR) for detection of copy amount variation of SMN1 and SMN2 genes for prognosis of SMA using scientific samples. For accuracy effectivity evaluation, ddPCR outcomes have been in distinction with these of multiplex ligation-dependent probe amplification (MLPA) as a reference regular. Copy numbers of SMN1/SMN2 exon 7 from 200 scientific samples have been concordant between ddPCR and MLPA.
Outcomes: For all samples, the copy number of SMN1/SMN2 exon 7 was concordant between MLPA and ddPCR. The ddPCR moreover confirmed acceptable ranges of repeatability and entire imprecision.
Conclusion: As a consequence of this reality, ddPCR is predicted to be useful for SMA prognosis and to predict phenotypic severity of SMA victims by determining the copy amount ofSMN2in scientific laboratories.
A multiplex PCR gear for the detection of three primary virulent genes in Enterococcus faecalis
A multiplex PCR gear that detects three primary virulence genes, gelE, hyl and asaI, in Enterococcus faecalis was developed. Analyses of the accessible sequences of the three primary virulence genes and the designed primers allowed us to develop the three-gene, multiplex PCR protocol that maintained the specificity of each primer pair. The following three amplicon bands for gelE, hyl and asaI have been even and distinct with product sizes of 213, 273 and 713 bp, respectively.
The multiplex PCR course of was validated with an entire of 243 E. faecalis strains that included 02 ATCC strains, 109 isolates from marine samples (sediment, water and sea meals), 22 isolates from cattle fodder, 79 isolates up to date water samples and 31isolates from nosocomial samples. Specificity of the gear was indicated by amplification of solely three primary virulence genes gelE, hyl and asaI, and with none nonspecific bands. Exams for the prohibit of detection revealed that amplified genes from the sample with a minimal of 104 CFU/g or CFU/mL (10 cells/response) of E. faecalis and reduce cell load samples, after a Three h enrichment in NIOT-E. faecalis enrichment medium at 37 °C, a sensitivity diploma of 10 CFU/g or CFU/mL was achieved.
GPR119 Antibody |
|||
| ABD4892 | Lifescience Market | 100 ug | 525.6 EUR |
GPR119 Antibody |
|||
| DF4892 | Affbiotech | 200ul | 420 EUR |
GPR119 Antibody |
|||
| 1-CSB-PA007283 | Cusabio |
|
|
|
Description: A polyclonal antibody against GPR119. Recognizes GPR119 from Human. This antibody is Unconjugated. Tested in the following application: WB, IF, ELISA;WB:1/500-1/2000.IF:1/200-1/1000.ELISA:1/10000 |
|||
GPR119 Antibody |
|||
| R35841-100UG | NSJ Bioreagents | 100 ug | 399 EUR |
Polyclonal Goat Anti-GPR119 Antibody |
|||
| APR16300G | Leading Biology | 0.1 mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Goat that recognizes and binds to Human Goat Anti-GPR119 . This antibody is tested and proven to work in the following applications: |
|||
Gpr119/ Rat Gpr119 ELISA Kit |
|||
| ELI-08203r | Lifescience Market | 96 Tests | 1063.2 EUR |
GPR119 Polyclonal Antibody |
|||
| 40973-100ul | SAB | 100ul | 302.4 EUR |
GPR119 Polyclonal Antibody |
|||
| 40973-50ul | SAB | 50ul | 224.4 EUR |
GPR119 Polyclonal Antibody |
|||
| ABP53820-003ml | Abbkine | 0.03ml | 189.6 EUR |
|
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
|||
GPR119 Polyclonal Antibody |
|||
| ABP53820-01ml | Abbkine | 0.1ml | 346.8 EUR |
|
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
|||
GPR119 Polyclonal Antibody |
|||
| ABP53820-02ml | Abbkine | 0.2ml | 496.8 EUR |
|
Description: A polyclonal antibody for detection of GPR119 from Human. This GPR119 antibody is for WB, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human GPR119 at AA rangle: 160-240 |
|||
GPR119 Polyclonal Antibody |
|||
| ES4819-100ul | ELK Biotech | 100ul | 334.8 EUR |
|
Description: A Rabbit Polyclonal antibody against GPR119 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
GPR119 Polyclonal Antibody |
|||
| ES4819-50ul | ELK Biotech | 50ul | 248.4 EUR |
|
Description: A Rabbit Polyclonal antibody against GPR119 from Human. This antibody is tested and validated for WB, ELISA, IF, WB, ELISA |
|||
GPR119 Peptide |
|||
| 45-692P | ProSci | 0.1 mg | 405.6 EUR |
|
Description: GPR119 Peptide |
|||
GPR119 siRNA |
|||
| 20-abx902267 | Abbexa |
|
|
GPR119 siRNA |
|||
| 20-abx918416 | Abbexa |
|
|
GPR119 siRNA |
|||
| 20-abx918417 | Abbexa |
|
|
GPR119 Polyclonal Conjugated Antibody |
|||
| C40973 | SAB | 100ul | 476.4 EUR |
GPR119 Blocking Peptide |
|||
| 20-abx162463 | Abbexa |
|
|
GPR119 Rabbit pAb |
|||
| A18544-100ul | Abclonal | 100 ul | 369.6 EUR |
GPR119 Rabbit pAb |
|||
| A18544-200ul | Abclonal | 200 ul | 550.8 EUR |
GPR119 Rabbit pAb |
|||
| A18544-20ul | Abclonal | 20 ul | 219.6 EUR |
GPR119 Rabbit pAb |
|||
| A18544-50ul | Abclonal | 50 ul | 267.6 EUR |
GPR119 Blocking Peptide |
|||
| DF4892-BP | Affbiotech | 1mg | 234 EUR |
GPR119 cloning plasmid |
|||
| CSB-CL840575HU-10ug | Cusabio | 10ug | 279.6 EUR |
|
Description: A cloning plasmid for the GPR119 gene. |
|||
Polyclonal GPR119 Antibody (aa186-235) |
|||
| APR16477G | Leading Biology | 0.05ml | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (aa186-235). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GPR119 Antibody (Cytoplasmic Domain) |
|||
| APR16478G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal GPR119 Antibody (Cytoplasmic Domain) |
|||
| APR16479G | Leading Biology | 0.05mg | 580.8 EUR |
|
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human GPR119 (Cytoplasmic Domain). This antibody is tested and proven to work in the following applications: |
|||
Polyclonal Goat anti-GST α-form |
|||
| GST-ANTI-1 | Detroit R&D | 50 uL | 336 EUR |
Polyclonal Goat anti-GST μ-form |
|||
| GST-ANTI-2 | Detroit R&D | 50 uL | 336 EUR |
Polyclonal Goat anti-GST p-form |
|||
| GST-ANTI-3 | Detroit R&D | 50 uL | 336 EUR |
Human GPR119 shRNA Plasmid |
|||
| 20-abx965265 | Abbexa |
|
|
Mouse GPR119 shRNA Plasmid |
|||
| 20-abx982252 | Abbexa |
|
|
Rat GPR119 shRNA Plasmid |
|||
| 20-abx989158 | Abbexa |
|
|
Human GPR119 ELISA KIT |
|||
| ELI-48829h | Lifescience Market | 96 Tests | 988.8 EUR |
Mouse Gpr119 ELISA KIT |
|||
| ELI-09750m | Lifescience Market | 96 Tests | 1038 EUR |
GPR119 Recombinant Protein (Human) |
|||
| RP039541 | ABM | 100 ug | Ask for price |
GPR119 Recombinant Protein (Rat) |
|||
| RP203282 | ABM | 100 ug | Ask for price |
GPR119 Recombinant Protein (Mouse) |
|||
| RP139418 | ABM | 100 ug | Ask for price |
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| 20-abx121407 | Abbexa |
|
|
G Protein-Coupled Receptor 119 (GPR119) Antibody |
|||
| 20-abx324143 | Abbexa |
|
|
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| abx432763-200ul | Abbexa | 200 ul | 460.8 EUR |
G-Protein Coupled Receptor 119 (GPR119) Antibody |
|||
| abx215630-100ug | Abbexa | 100 ug | 526.8 EUR |
Gpr119 ORF Vector (Rat) (pORF) |
|||
| ORF067762 | ABM | 1.0 ug DNA | 607.2 EUR |
GPR119 ORF Vector (Human) (pORF) |
|||
| ORF013181 | ABM | 1.0 ug DNA | 424.8 EUR |
Gpr119 ORF Vector (Mouse) (pORF) |
|||
| ORF046474 | ABM | 1.0 ug DNA | 607.2 EUR |
Gpr119 sgRNA CRISPR Lentivector set (Rat) |
|||
| K7204201 | ABM | 3 x 1.0 ug | 406.8 EUR |
GPR119 sgRNA CRISPR Lentivector set (Human) |
|||
| K0895801 | ABM | 3 x 1.0 ug | 406.8 EUR |
Gpr119 sgRNA CRISPR Lentivector set (Mouse) |
|||
| K3605701 | ABM | 3 x 1.0 ug | 406.8 EUR |
Gpr119 sgRNA CRISPR Lentivector (Rat) (Target 1) |
|||
| K7204202 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr119 sgRNA CRISPR Lentivector (Rat) (Target 2) |
|||
| K7204203 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr119 sgRNA CRISPR Lentivector (Rat) (Target 3) |
|||
| K7204204 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR119 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
| K0895802 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR119 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
| K0895803 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR119 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
| K0895804 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr119 sgRNA CRISPR Lentivector (Mouse) (Target 1) |
|||
| K3605702 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr119 sgRNA CRISPR Lentivector (Mouse) (Target 2) |
|||
| K3605703 | ABM | 1.0 ug DNA | 184.8 EUR |
Gpr119 sgRNA CRISPR Lentivector (Mouse) (Target 3) |
|||
| K3605704 | ABM | 1.0 ug DNA | 184.8 EUR |
GPR119 Protein Vector (Human) (pPB-C-His) |
|||
| PV052721 | ABM | 500 ng | 577.2 EUR |
GPR119 Protein Vector (Human) (pPB-N-His) |
|||
| PV052722 | ABM | 500 ng | 577.2 EUR |
GPR119 Protein Vector (Human) (pPM-C-HA) |
|||
| PV052723 | ABM | 500 ng | 577.2 EUR |
GPR119 Protein Vector (Human) (pPM-C-His) |
|||
| PV052724 | ABM | 500 ng | 577.2 EUR |
GPR119 Protein Vector (Mouse) (pPB-C-His) |
|||
| PV185894 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Mouse) (pPB-N-His) |
|||
| PV185895 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Mouse) (pPM-C-HA) |
|||
| PV185896 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Mouse) (pPM-C-His) |
|||
| PV185897 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Rat) (pPB-C-His) |
|||
| PV271046 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Rat) (pPB-N-His) |
|||
| PV271047 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Rat) (pPM-C-HA) |
|||
| PV271048 | ABM | 500 ng | 723.6 EUR |
GPR119 Protein Vector (Rat) (pPM-C-His) |
|||
| PV271049 | ABM | 500 ng | 723.6 EUR |
GPR119 3'UTR Luciferase Stable Cell Line |
|||
| TU009210 | ABM | 1.0 ml | 2799.6 EUR |
Gpr119 3'UTR GFP Stable Cell Line |
|||
| TU255325 | ABM | 1.0 ml | Ask for price |
GPR119 3'UTR GFP Stable Cell Line |
|||
| TU059210 | ABM | 1.0 ml | 2799.6 EUR |
Gpr119 3'UTR Luciferase Stable Cell Line |
|||
| TU205325 | ABM | 1.0 ml | Ask for price |
Gpr119 3'UTR Luciferase Stable Cell Line |
|||
| TU108968 | ABM | 1.0 ml | Ask for price |
Gpr119 3'UTR GFP Stable Cell Line |
|||
| TU158968 | ABM | 1.0 ml | Ask for price |
GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV) |
|||
| LV629167 | ABM | 1.0 ug DNA | 818.4 EUR |
GPR119 Lentiviral Vector (Rat) (UbC) (pLenti-GIII-UbC) |
|||
| LV629171 | ABM | 1.0 ug DNA | 818.4 EUR |
GPR119 Lentiviral Vector (Rat) (EF1a) (pLenti-GIII-EF1a) |
|||
| LV629172 | ABM | 1.0 ug DNA | 818.4 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Rat) |
|||
| K7204205 | ABM | 3 x 1.0 ug | 451.2 EUR |
GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
| K0895805 | ABM | 3 x 1.0 ug | 451.2 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Mouse) |
|||
| K3605705 | ABM | 3 x 1.0 ug | 451.2 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1) |
|||
| K7204206 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 2) |
|||
| K7204207 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 3) |
|||
| K7204208 | ABM | 1.0 ug DNA | 200.4 EUR |
GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-C-term-HA) |
|||
| LV629168 | ABM | 1.0 ug DNA | 818.4 EUR |
GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro) |
|||
| LV629169 | ABM | 1.0 ug DNA | 888 EUR |
GPR119 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro) |
|||
| LV629170 | ABM | 1.0 ug DNA | 888 EUR |
GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 1) |
|||
| K0895806 | ABM | 1.0 ug DNA | 200.4 EUR |
GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 2) |
|||
| K0895807 | ABM | 1.0 ug DNA | 200.4 EUR |
GPR119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Human) (Target 3) |
|||
| K0895808 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 1) |
|||
| K3605706 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2) |
|||
| K3605707 | ABM | 1.0 ug DNA | 200.4 EUR |
Gpr119 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 3) |
|||
| K3605708 | ABM | 1.0 ug DNA | 200.4 EUR |
Anti-Anti-SEPT6 antibody antibody |
|||
| STJ11100949 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
|||
Anti-Anti-SEPT9 Antibody antibody |
|||
| STJ111369 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
|||
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ111530 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT4 Antibody antibody |
|||
| STJ112276 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
|||
Anti-Anti-MARCH9 Antibody antibody |
|||
| STJ112609 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ113941 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT11 Antibody antibody |
|||
| STJ114081 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ114819 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-MARCH8 Antibody antibody |
|||
| STJ114828 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ116214 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ117206 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT12 Antibody antibody |
|||
| STJ117759 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118549 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH6 Antibody antibody |
|||
| STJ118550 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-MARCH7 Antibody antibody |
|||
| STJ118752 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT3 Antibody antibody |
|||
| STJ118990 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ28365 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT7 Antibody antibody |
|||
| STJ28963 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
|||
Anti-Anti-SEPT2 Antibody antibody |
|||
| STJ25475 | St John's Laboratory | 100 µl | 332.4 EUR |
Anti-Anti-SEPT5 Antibody antibody |
|||
| STJ25477 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
|||
Anti-Anti-SEPT8 Antibody antibody |
|||
| STJ25479 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
|||
Anti-Anti-SEPT1 antibody antibody |
|||
| STJ119580 | St John's Laboratory | 100 µl | 332.4 EUR |
|
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
|||
Anti-Anti-DDB1 Antibody |
|||
| A00333 | BosterBio | 100uL | 546 EUR |
|
Description: Rabbit Polyclonal DDB1 Antibody. Validated in IP and tested in Human, Mouse. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-10x96wellstestplate | Cloud-Clone | 10x96-wells test plate | 6777.36 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x48wellstestplate | Cloud-Clone | 1x48-wells test plate | 663.31 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-1x96wellstestplate | Cloud-Clone | 1x96-wells test plate | 896.16 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| AEA465Hu-5x96wellstestplate | Cloud-Clone | 5x96-wells test plate | 3672.72 EUR |
|
Description: This is Competitive Enzyme-linked immunosorbent assay for Antibody Detection.detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in serum, plasma and other biological fluids. |
|||
Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) ELISA Kit |
|||
| 4-AEA465Hu | Cloud-Clone |
|
|
|
Description: Enzyme-linked immunosorbent assay based on the Competitive Inhibition method for detection of Human Anti-Anti-Sperm Antibody Antibody (Anti-AsAb) in samples from serum, plasma and other biological fluids with no significant corss-reactivity with analogues from other species. |
|||
ELISA kit for Human Anti-AsAb (Anti-Anti-Sperm Antibody Antibody) |
|||
| ELK8071 | ELK Biotech | 1 plate of 96 wells | 518.4 EUR |
|
Description: A competitive Inhibition ELISA kit for detection of Anti-Anti-Sperm Antibody Antibody from Human in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
|||
Anti-ZNF660 antibody |
|||
| 44742-100ul | SAB | 100ul | 302.4 EUR |
Anti-ZNF660 antibody |
|||
| 44742-50ul | SAB | 50ul | 224.4 EUR |
Anti-CCV Antibody |
|||
| 10-2789 | Fitzgerald | 1 mg | 217.2 EUR |
|
Description: Anti-Canine Corona Virus Antibody |
|||
Anti-CCV Antibody |
|||
| 10-2790 | Fitzgerald | 1 mg | 217.2 EUR |
|
Description: Anti-Canine Corona Virus Antibody |
|||
Anti-CDV antibody |
|||
| 10-2791 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CDV antibody |
|||
| 10-2792 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CDV antibody |
|||
| 10-2793 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CDV antibody |
|||
| 10-2794 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Canine Distemper Virus antibody |
|||
Anti-CPV Antibody |
|||
| 10-2795 | Fitzgerald | 500 uig | 165.6 EUR |
|
Description: Anti-Canine Parvo Virus Antibody |
|||
Anti-CPV Antibody |
|||
| 10-2796 | Fitzgerald | 500 ug | 165.6 EUR |
|
Description: Anti-Canine Parvo Virus Antibody |
|||
Anti-CPV Antibody |
|||
| 10-2797 | Fitzgerald | 500 ug | 165.6 EUR |
|
Description: Anti-Canine Parvo Virus Antibody |
|||
Anti-C.CRP antibody |
|||
| 10-2798 | Fitzgerald | 500 ug | 165.6 EUR |
|
Description: Anti-Canine CRP antibody |
|||
Anti-C.CRP antibody |
|||
| 10-2799 | Fitzgerald | 500 ug | 165.6 EUR |
|
Description: Anti-Canine CRP antibody |
|||
Anti-CHW antibody |
|||
| 10-2800 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Canine Heartworm antibody |
|||
Anti-FeLV antibody |
|||
| 10-2801 | Fitzgerald | 1 mg | 217.2 EUR |
|
Description: Anti-Feline Leukemia Virus antibody |
|||
Anti-FeLV antibody |
|||
| 10-2802 | Fitzgerald | 1 mg | 217.2 EUR |
|
Description: Anti-Feline Leukemia Virus antibody |
|||
Anti-FeLV antibody |
|||
| 10-2803 | Fitzgerald | 1 mg | 217.2 EUR |
|
Description: Anti-Feline Leukemia Virus antibody |
|||
Anti-PGI antibody |
|||
| 10-2806 | Fitzgerald | 1 mg | 502.8 EUR |
|
Description: Anti-PGI recombinant antibody |
|||
Anti-PGI antibody |
|||
| 10-2807 | Fitzgerald | 1 mg | 502.8 EUR |
|
Description: Anti-PGI recombinant antibody |
|||
Anti-PGII antibody |
|||
| 10-2808 | Fitzgerald | 1 mg | 502.8 EUR |
|
Description: Anti-PGII recombinant antibody |
|||
Anti-PGII antibody |
|||
| 10-2809 | Fitzgerald | 1 mg | 502.8 EUR |
|
Description: Anti-PGII recombinant antibody |
|||
Anti-CHW antibody |
|||
| 10-2810 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-CHW monoclonal antibody |
|||
Anti-Giardia antibody |
|||
| 10-2811 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Giardia monoclonal antibody |
|||
Anti-Giardia antibody |
|||
| 10-2812 | Fitzgerald | 1 mg | 198 EUR |
|
Description: Anti-Giardia monoclonal antibody |
|||
Anti-TAP1 Antibody |
|||
| A01123 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal TAP1 Antibody. Validated in IP, IHC, WB and tested in Human, Rat. |
|||
Anti-CHD4 Antibody |
|||
| A01125 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal CHD4 Antibody. Validated in IF, IHC and tested in Human, Mouse. |
|||
Anti-NRF1 Antibody |
|||
| A01129-2 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-MEF2C Antibody |
|||
| A01131-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-SCN4A Antibody |
|||
| A01138 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal SCN4A Antibody. Validated in WB and tested in Human. |
|||
Anti-MTR Antibody |
|||
| A01140-2 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-IL12B Antibody |
|||
| A01152-2 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-IL12B Antibody |
|||
| A01152-3 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-IL12B Antibody |
|||
| A01152-4 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-IL11 Antibody |
|||
| A01160-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-Bak Antibody |
|||
| A01163 | BosterBio | 200ug | 626.4 EUR |
|
Description: Rabbit Polyclonal Bak Antibody. Validated in IP, IF, IHC, WB and tested in Human. |
|||
Anti-PGF Antibody |
|||
| A01164-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-PGF Antibody |
|||
| A01164-2 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-CD201 Antibody |
|||
| A01166 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for CD201 Antibody (PROCR) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-SERCA2 Antibody |
|||
| A01176 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for SERCA2 Antibody (ATP2A2) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-XPA Antibody |
|||
| A01182 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal XPA Antibody. Validated in IHC, WB and tested in Human. |
|||
Anti-XPA Antibody |
|||
| A01182-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for XPA Antibody (XPA) detection.tested for WB in Human, Mouse. |
|||
Anti-XPA Antibody |
|||
| A01182-2 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-BNP Antibody |
|||
| A01186-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal BNP Antibody. Validated in IF, IHC, WB and tested in Mouse, Rat. |
|||
Anti-CD1c Antibody |
|||
| A01188-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-CDC7 Antibody |
|||
| A01190 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal CDC7 Antibody. Validated in WB and tested in Human. |
|||
Anti-VCAM1 Antibody |
|||
| A01199 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-VCAM1 Antibody |
|||
| A01199-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-VCAM1 Antibody |
|||
| A01199-2 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-MAP2 Antibody |
|||
| A01201 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-MAP2 Antibody |
|||
| A01201-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal MAP2 Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
|||
Anti-RING1B Antibody |
|||
| A01209-1 | BosterBio | 100ug | 546 EUR |
|
Description: Goat Polyclonal RING1B Antibody. Validated in IF, WB and tested in Human, Mouse, Rat. |
|||
Anti-MUC2 Antibody |
|||
| A01212 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-C1INH Antibody |
|||
| A01221 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for C1INH Antibody (SERPING1) detection.tested for WB in Human. |
|||
Anti-WWOX Antibody |
|||
| A01223-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-RNF168 Antibody |
|||
| A01224-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-HDAC5 Antibody |
|||
| A01230-5 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-Dysferlin Antibody |
|||
| A01234-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Dysferlin Antibody. Validated in WB and tested in Human, Mouse. |
|||
Anti-LPP Antibody |
|||
| A01240-2 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-p57 Antibody |
|||
| A01244 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for p57 Antibody (CDKN1C) detection.tested for IHC, WB in Human, Mouse, Rat. |
|||
Anti-MDC1 Antibody |
|||
| A01252-2 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-FHL Antibody |
|||
| A01258-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-FHL Antibody |
|||
| A01258-2 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-ACBP Antibody |
|||
| A01267-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for ACBP Antibody (DBI) detection. Tested with WB in Human, Mouse, Rat. |
|||
Anti-PDK1 Antibody |
|||
| A01268 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for PDK1 Antibody (PDK1) detection. Tested with WB in Human, Mouse, Rat. |
|||
Anti-CD81 Antibody |
|||
| A01281-1 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Antibody for CD81 Antibody (CD81) detection. Tested with WB in Human, Mouse, Rat. |
|||
Anti-CHI3L1 Antibody |
|||
| A01283-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-HLF Antibody |
|||
| A01284-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-BRD7 Antibody |
|||
| A01289-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-Endostatin Antibody |
|||
| A01302 | BosterBio | 100ul | 476.4 EUR |
|
Description: Rabbit Polyclonal Endostatin Antibody. Validated in IHC and tested in Human. |
|||
Anti-COL18A1 Antibody |
|||
| A01302-1 | BosterBio | 100ug/vial | 352.8 EUR |
Anti-SATB1 Antibody |
|||
| A01312-1 | BosterBio | 100ug/vial | 400.8 EUR |
Anti-TCF7 Antibody |
|||
| A01315-2 | BosterBio | 100ug/vial | 352.8 EUR |
